Russell Investments Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-68,778
| Closed | -$17K | – | 4502 |
|
|
2026
Q1 | $17K | Buy |
68,778
+18,421
| +37% | +$7.33K | ﹤0.01% | 3664 |
|
|
2025
Q4 | $21.1K | Sell |
50,357
-296
| -0.6% | -$157 | ﹤0.01% | 3612 |
|
|
2025
Q3 | $34.1K | Buy |
50,653
+17,505
| +53% | +$9.44K | ﹤0.01% | 3422 |
|
|
2025
Q2 | $17.9K | Sell |
33,148
-105
| -0.3% | -$62 | ﹤0.01% | 3222 |
|
|
2025
Q1 | $21.8K | Buy |
33,253
+6,939
| +26% | +$7.35K | ﹤0.01% | 3093 |
|
|
2024
Q4 | $26.8K | Sell |
26,314
-14,492
| -36% | -$26.5K | ﹤0.01% | 2955 |
|
|
2024
Q3 | $35.3K | Buy |
40,806
+18,229
| +81% | +$13.4K | ﹤0.01% | 2848 |
|
|
2024
Q2 | $8.09K | Buy |
22,577
+16,299
| +260% | +$8.81K | ﹤0.01% | 3125 |
|
|
2024
Q1 | $4.21K | Sell |
6,278
-94,744
| -94% | -$68.7K | ﹤0.01% | 2966 |
|
|
2023
Q4 | $54.9K | Sell |
101,022
-1,279
| -1% | -$590 | ﹤0.01% | 2629 |
|
|
2023
Q3 | $61.4K | Sell |
102,301
-2,387
| -2% | -$2.56K | ﹤0.01% | 2718 |
|
|
2023
Q2 | $136K | Sell |
104,688
-91,218
| -47% | -$125K | ﹤0.01% | 2548 |
|
|
2023
Q1 | $345K | Buy |
195,906
+94,545
| +93% | +$270K | ﹤0.01% | 2366 |
|
|
2022
Q4 | $318K | Hold |
101,361
| – | – | ﹤0.01% | 2444 |
|
|
2022
Q3 | $496K | Buy |
101,361
+67,961
| +203% | +$349K | ﹤0.01% | 2248 |
|
|
2022
Q2 | $138K | Buy |
+33,400
| New | +$144K | ﹤0.01% | 2612 |
|
|
2021
Q2 | – | Sell |
-77,714
| Closed | -$964K | – | 3286 |
|
|
2021
Q1 | $964K | Sell |
77,714
-32,369
| -29% | -$436K | ﹤0.01% | 2261 |
|
|
2020
Q4 | $1.72M | Sell |
110,083
-6,788
| -6% | -$79.5K | ﹤0.01% | 1838 |
|
|
2020
Q3 | $1.1M | Buy |
116,871
+8,500
| +8% | +$91.9K | ﹤0.01% | 2023 |
|
|
2020
Q2 | $971K | Buy |
108,371
+51,091
| +89% | +$474K | ﹤0.01% | 2073 |
|
|
2020
Q1 | $364K | Sell |
57,280
-44,012
| -43% | -$327K | ﹤0.01% | 2316 |
|
|
2019
Q4 | $846K | Hold |
101,292
| – | – | ﹤0.01% | 2187 |
|
|
2019
Q3 | $917K | Buy |
101,292
+1,833
| +2% | +$20.6K | ﹤0.01% | 2046 |
|
|
2019
Q2 | $1.07M | Hold |
99,459
| – | – | ﹤0.01% | 1955 |
|
|
2019
Q1 | $948K | Hold |
99,459
| – | – | ﹤0.01% | 2092 |
|
|
2018
Q4 | $1.14M | Sell |
99,459
-6,435
| -6% | -$79.9K | ﹤0.01% | 1880 |
|
|
2018
Q3 | $1.79M | Buy |
105,894
+69,984
| +195% | +$1.06M | ﹤0.01% | 1812 |
|
|
2018
Q2 | $509K | Hold |
35,910
| – | – | ﹤0.01% | 2386 |
|
|
2018
Q1 | $682K | Sell |
35,910
-3,045
| -8% | -$65.1K | ﹤0.01% | 2362 |
|
|
2017
Q4 | $665K | Sell |
38,955
-31,719
| -45% | -$472K | ﹤0.01% | 2333 |
|
|
2017
Q3 | $1.06M | Buy |
70,674
+47,579
| +206% | +$526K | ﹤0.01% | 2113 |
|
|
2017
Q2 | $203K | Buy |
+23,095
| New | +$148K | ﹤0.01% | 2688 |
|
|
2017
Q1 | – | Sell |
-58,739
| Closed | -$179K | – | 3065 |
|
|
2016
Q4 | $179K | Buy |
+58,739
| New | +$214K | ﹤0.01% | 2735 |
|
Other funds holding SGMO
Russell Investments Group's SGMO Position: Q2 2026 in Review
Russell Investments Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 68,778 shares — an estimated $17K sold.
Russell Investments Group first reported a position in SGMO in Q4 2016 and held it in 33 quarters. The position peaked at $1.79M in Q3 2018. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.
- Russell Investments Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
- Russell Investments Group sold 68,778 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $17K.
- Russell Investments Group first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and held it in 33 quarters.
- Russell Investments Group's SANGAMO THERAPEUTICS INC position peaked at $1.79M in Q3 2018.
- 2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.